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The incidence of diabetes is rising globally. Similarly, there has also been a rise in the 
incidence of diabetes in pregnancy, both pre-gestational as well as gestational. These 
patients are at risk of multiple perinatal complications, including macrosomia. There is an 
increased risk of perinatal complications with a fetal weight at birth of more than 4 000 g, 
especially if macrosomia occurs in the context of diabetes.  In order to predict fetal 
macrosomia, fetal weight estimation remains an important component of antenatal 
surveillance. Despite the relative inaccuracy of ultrasound fetal weight estimation, the 
current National Institute for Health and Care Excellence (NICE) guideline on the care of 
diabetic patients, recommends offering 4 weekly ultrasound scans from 28 to 36 weeks to 
assess fetal growth and wellbeing. In addition, the Western Cape guidelines recommend 
offering an elective caesarean section to diabetic patients with an estimated fetal weight of 
4 000 g or more at term with a fetal abdominal circumference greater than the 90th 
percentile. This practice has subsequently resulted in a large number of caesarean 




The aim of this study was to assess the accuracy of ultrasound fetal weight estimation 
performed in diabetic women at term, as well as to determine the incidence of macrosomia 
in the study population and the accuracy of ultrasound identification of macrosomia. 
 
Methods 
A retrospective audit was undertaken in women who attended antenatal services at Groote 
Schuur Hospital (GSH). This study reviewed women with an abnormal glucose tolerance 
test (GTT) during pregnancy or with known diabetes preceding pregnancy attending GSH 
during a 12-month period were included.  Women with a singleton pregnancy at 36 weeks 
or more that underwent a documented ultrasound for fetal weight estimation within 7 days 
of delivery were included in this audit.  
 




A total of 97 women in the study population met the inclusions criteria.  Seventy patients 
(72%) had gestational diabetes and 22 (18%) had pre-gestational diabetes.  Ultrasound 
weight estimations were accurate to within 10% of birth weight in 70,1% of all patients.  
Eleven (11,3%) patients had macrosomic (> 4 000 g) babies.  In these patients only 54,5% 
of fetal weight estimations were accurate to within 10% of birth weight.  Ultrasound for 




The accuracy of ultrasound fetal weight estimation performed in diabetic patients at GSH 
appears similar to that of other international studies.  Ultrasound estimations become 
increasingly inaccurate in extremes of fetal weight.  One in four fetal weight estimations 
had an estimation error of > 10% with a tendency towards underestimation in macrosomic 
fetuses. Ultrasound fetal weight estimation as a predictor for fetal macrosomia should 
therefore remain under scrutiny, especially in the context of the high perinatal morbidity 
associated with macrosomia and shoulder dystocia as well as the rising litigation related to 
birth complications.   
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Background and Literature Review 
 
Introduction 
Diabetes mellitus (DM) has a rapidly rising global incidence with an estimated 366 million 
people affected in 2011.  This is according to global estimates compiled by the 
International Diabetes Federation (IDF), based on data from 170 selected data sources 
from 110 countries. The global incidence is expected to rise by 50.7% with an expected 
552 million people affected by DM in 2030.  An alarming increase in incidence of 92% is 
predicted for low-income countries.  The African continent is expected to have the largest 
proportional increase in numbers by 2030. In South Africa, the IDF estimated the incidence 
of DM to be 7% among adults between the age of 20 and 79 years in 2011.  The incidence 
is amongst the highest in Africa and is expected to rise to 7,9% in 2030. [1] 
Motala et al. conducted a cross sectional survey in a rural South African community of 
Zulu descent, using the 1998 World Health Organization criteria for disorders of glycaemia.  
They found a moderate age-adjusted prevalence of 3,9% for DM.  The age-adjusted 
prevalence for total disorders of glycaemia (including impaired glucose tolerance and 
impaired fasting glycaemia) was as high as 10,2%. Eighty-four percent of the cases of DM 
were newly diagnosed during the survey. [2] 
Diabetes in pregnancy 
With the rising burden of DM globally, hyperglycaemia in pregnancy poses a major threat 
to maternal health worldwide.  Global estimates presented by the IDF indicate a high 
prevalence.   An estimated 21,4 million live births, with a rate of 170 cases per 1 000 live 
births, were affected by hyperglycaemia in pregnancy in 2013.  More than 90% of these 
cases occurred in low- and middle-income countries. [1] 
It is postulated that the DM epidemic is driven by lifestyle changes attributed to 
urbanization and development.  Inadequate nutrition as well as a low level of physical 
activity leads to central obesity and an increased risk of metabolic disorders including DM.  
In high-income and upper-middle income countries changing fertility patterns are also 
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affecting the prevalence of hyperglycaemia in pregnancy as women often opt to have 
children later in their lives.  The prevalence of hyperglycaemia in pregnancy is estimated to 
be as high as 39,2% at the age of 40 years or older. [3] 
 
Approximately 5% of pregnancies in England and Wales are complicated by diabetes.  It is 
estimated that 87,5% of these patients have gestational diabetes, 7,5% Type 1 diabetes 
and 5% Type 2 diabetes. [4] In the United States, when using the traditional diagnostic 
criteria, the incidence of diabetes in pregnancy is 6 to 7%. [5] 
 
There is a paucity of available literature on the incidence of diabetes in pregnancy in South 
Africa.  One study conducted by Mamabolo et al. in the Limpopo province, found an 8,8% 
rate of gestational diabetes.  This study included 262 women and screening was done in 
the third trimester of pregnancy. [6]  
 
Diagnostic criteria 
The International Association of Diabetes and Pregnancy Study Group (IADPSG) 
proposed new criteria to diagnose diabetes in pregnancy in 2010.  This was based on the 
findings of the landmark hyperglycaemia and adverse pregnancy outcomes (HAPO) study. 
This multi-center cross sectional study found strong evidence to suggest that maternal 
glucose levels lower than the diagnostic levels for diabetes in pregnancy, is also 
associated with adverse pregnancy outcomes. The IADPSG suggests two phase 
screening in pregnancy.  This consists of early screening, aimed at diagnosing women 
with pre-existing diabetes not previously diagnosed, as well as an oral glucose tolerance 
test (GTT) at 24 to 28 weeks’ gestation in all women not previously found to have 
diabetes.  If the fasting blood glucose is 7,0 mmol/l or more, diabetes is diagnosed.  
Gestational diabetes is diagnosed if the fasting blood sugar is > 5,1 mmol/l, the 1-hour 
blood sugar > 10,0 mmol/l or the 2-hour blood sugar > 8,5 mmol/l.  These values are much 
lower than those used previously.  If these criteria are adopted, this will lead to a marked 
increase in the incidence of diabetes in pregnancy.  When using these criteria, the global 
incidence is estimated at 17%. [3,7] These criteria have not yet been widely adopted in the 
South African setting. 
 
 




In pregnancy, diabetes is associated with multiple perinatal complications.  The diabetic 
mother is at an increased risk of pre-eclampsia and preterm labour.  The fetus of the 
diabetic mother is at an increased risk of congenital malformations, perinatal mortality and 
stillbirth, as well as macrosomia and its associated morbidity. [4]  
The exact definition of macrosomia remains contentious. The Royal College of 
Obstetricians and Gynaecologists (RCOG) defines macrosomia as a fetal weight at birth of 
5 000 g or more in normal pregnancies or a fetal weight at birth of 4 500 g or more in 
pregnancies affected by diabetes. [8] The American College of Obstetricians and 
Gynecologists (ACOG) is more conservative, with macrosomia defined as a fetal weight at 
birth greater than 4 500 g as both fetal and maternal morbidity shows a sharp increase at 
this cut off.  It is, however, recognized that the risk is already increased with a fetal weight 
at birth of more than 4 000 g. [9]  
 
Maternal risks specifically associated with a macrosomic fetus include prolonged or 
obstructed labour, operative vaginal delivery, increased risk of caesarean delivery, 
perineal trauma, post-partum haemorrhage and uterine rupture.  The macrosomic fetus is 
at risk of shoulder dystocia with or without trauma e.g. brachial plexus injury or fractures. 
There is also an increased risk of birth asphyxia, meconium aspiration and the need for 
assisted ventilation.  The risk of mortality increases proportionately to weight and rises 
sharply in infants who weigh 5 000 g or more. [10, 11] 
Langer et al. examined a cohort of 75 979 women who delivered vaginally and stratified 
them into a diabetic and a non-diabetic group.  In the non-diabetic group, 7,6% of the 
women delivered a baby with a birth weight of 4 000 g or more, compared to 20,6% of the 
women in the diabetic group.  The rate of shoulder dystocia in the non-diabetic group was 
0,3%, compared to a 3,2% rate in the diabetic patients.  There was a 3-fold higher risk for 
shoulder dystocia in diabetic patients with a macrosomic fetus. [12] The increased risk of 
shoulder dystocia in macrosomic fetuses in the diabetic population can be explained by 
the different patterns of fat distribution in the non-diabetic and diabetic fetus.  In the fetus 
of a non-diabetic mother, large fetal size is generally genetically determined with the fat 
distribution similar to that of smaller fetuses.  In diabetic patients the fetus is exposed to 
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high plasma glucose levels during pregnancy, leading to fetal hyper-insulinaemia.  Insulin 
acts as a growth factor and increased levels lead to a disproportionate deposition of fat in 
the fetal trunk and shoulders, as well as organomegaly.  This results in an increased 
abdominal and shoulder circumference, which in turn leads to an increased risk for 
shoulder dystocia. [12] 
 
Nassar et al., in their work across a 12-year period between 1984 and 1996, described a 
7,7% risk of fetal trauma in patients who delivered a macrosomic fetus weighing more than 
4 500 g vaginally. [13]  
 
Rouse et al., in their review of qualitative data, described the risk of brachial plexus injury 
with shoulder dystocia to be 9% in fetuses weighing less than 4 000 g, 18% if the fetal 
weight is between 4 000 g and 4 499 g and 26% with a fetal weight of 4 500 g or more.  
Many of these injuries recovered over time, although the probability of a brachial plexus 
injury resulting in permanent disability was 6,7% in their review. [14] 
 
Fetal weight estimation in the diabetic population, therefore, remains an important 
component of antenatal surveillance, especially in the late third trimester.   
 
Methods of estimating fetal weight 
Prior to real-time ultrasound being widely accessible, clinical fetal weight estimation was 
the gold standard.  A retrospective cohort study by Goetzinger et al. evaluated the 
accuracy of clinical fetal weight estimation in 3 797 patients at term.  The correlation 
between clinical estimation and actual birth weight was poor, with an absolute error in 
clinical estimate of more than 500 g in 24,8% of patients.  Body mass index (BMI), fetal 
station and admission diagnosis did not play a statistically significant role.  Clinical weight 
estimations had a very low detection rate for fetal macrosomia (fetal weight > 4 000 g) with 
only 18,1% of macrosomic fetuses correctly identified antenatally. [15]  
 
The initial assumption was that ultrasound fetal weight estimation would be superior to 
clinical estimates.  A number of studies have subsequently compared different methods of 
fetal weight estimation including clinical palpation, maternal estimation and ultrasound 
estimation.  In 2002 in the USA, Diase and Monga found no statistically significant 
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difference in the accuracy of fetal weight estimation when comparing these 3 different 
methods in 32 diabetic patients at term. [16] A larger study, including 200 patients, by Baum 
et al. directly compared clinical palpation with ultrasound fetal weight estimation.  Patients 
with singleton pregnancies at 37 to 42 weeks’ gestation were included in this study.  They 
concluded that ultrasound was not superior to clinical estimation, with 64% of clinical 
estimates compared to 62,5% of ultrasound estimates being within 10% of actual birth 
weight. [17]  
 
At the extremes of fetal weight clinical estimates become less accurate.  In low birth weight 
fetuses (< 2 500 g), ultrasound estimation of fetal weight has been shown to be more 
accurate than clinical estimation.  In the macrosomic group (> 4 000 g) both ultrasound 
and clinical estimates become more inaccurate, with ultrasound underestimating and 
clinical palpation overestimating the number of macrosomic fetuses according to a 
Nigerian study by Shittu et al. [18] A systematic underestimation of fetal weight in diabetic 
patients was noted in a New Zealand study by Colman et al. [19] Wong et al. reported 
similar findings in a study in 2001 and the authors suggested that diabetes in pregnancy 
could lead to an increase in soft tissue mass and liver size in these fetuses.  The 
ultrasound formulae might therefore be less accurate as it does not account for this 
difference. [20]  
 
However, a study by Alsulyman et al. found no statistically significant difference in the 
mean absolute percent error and therefore in the accuracy of fetal weight prediction 
between the diabetic and non-diabetic population when matched for maternal body mass 
index and birth weight (9,0% ± 7,1% vs. 8,4% ± 6,3%).  They concluded that a birth weight 
of more than 4 500 g rather than maternal diabetes influenced the accuracy of ultrasound 
fetal weight estimation. Hadlock’s formula for fetal weight prediction demonstrates a mean 
absolute error of 13% when the birth weight is > 4 500 g compared to only 8% with a birth 
weight below 4 500 g. [21] 
 
A study conducted by Ben-Haroush et al. in Israel consisted of 840 women with singleton 
pregnancies who had an ultrasound fetal weight estimation within 3 days of undergoing 
induction of labour.  They demonstrated a good correlation between the sonographic 
estimated fetal weight and birth weight with an overall accuracy to within 10% of birth 
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weight in 74,4% of patients.  They noted that independent factors that significantly reduced 
the accuracy of ultrasound estimation of fetal weight included prematurity, increased birth 
weight, anterior placental location, higher gravidity and younger maternal age, although 
this was not thought to have clinical significance.  The study cohort included both diabetic 
and non-diabetic patients.  Seventy-four (8,8%) of patients in this study had fetuses with a 
birth weight greater than 4 000 g.  The sensitivity and specificity of ultrasound in the 
prediction of macrosomia in this group was 47% and 95% respectively, with a positive 
predictive value of 46% and a negative predictive value of 95%. [22] 
 
Ultrasound fetal weight estimation 
The earliest method of ultrasound fetal weight estimation included only an abdominal 
circumference method.  Further attempts to improve the accuracy led to the use of multiple 
growth parameters in different regression equations or volumetric formulae.  A systematic 
review published by the International Society of Ultrasound in Obstetrics and Gynaecology 
in 2004 compared multiple different methods.  They concluded that there was no 
statistically significant difference between the accuracy of these different methods. [23]  
 
In the systematic review by the International Society of Ultrasound in Obstetrics and 
Gynaecology, inter- and intra-observer variability remained a significant factor affecting the 
accuracy of ultrasound fetal weight estimation.  The proposed methods to minimize this 
include: 
 
•   multiple measurements  
•   optimal image quality  
•   uniform equipment calibration 
•   appropriate measurement methods. [23]  
 
Ultrasound in pregnancies complicated by diabetes 
Despite these previous studies, the current National Institute for Health and Care 
Excellence (NICE) guideline on the care of diabetic patients recommends offering 
ultrasound 4 weekly from 28 to 36 weeks to assess fetal growth and wellbeing. [4]  
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The South African national guidelines recommend a dating ultrasound for all patients.  In 
addition, it is recommended that diabetic patients have a nuchal translucency scan as well 
as a detailed fetal anomaly scan done at a specialist level hospital. [24] The current protocol 
for management of diabetic patients at Groote Schuur Hospital (GSH) goes further and 
recommends that ultrasound to measure growth be done at 4 weekly intervals 
commencing at 28 weeks.  In addition, the Western Cape guidelines recommend offering 
an elective caesarean section to diabetic patients with an estimated fetal weight of 4000 g 
or more at term with a fetal abdominal circumference greater than the 90th centile. [25] This 
is also the practice at the Maternity Centre at GSH and has subsequently resulted in a 
large number of caesarean deliveries performed to prevent fetal and maternal morbidity 
related to presumed macrosomia. 
 
Caesarean section for suspected macrosomia 
Rouse et al. found a rate of 489 caesarean sections done for infants with a suspected birth 
weight greater than 4 000 g in diabetic patients to prevent one case of permanent brachial 
plexus injury. [14] 
 
There has been much debate on an acceptable caesarean section rate globally with a 
wide range in both developed and developing countries.  The national caesarean section 
rate is 23% as published in the Saving Mothers report (2011 – 2013).  Haemorrhage 
remains an important cause of maternal mortality both in South Africa and worldwide.  The 
high number of maternal deaths related to haemorrhage associated with caesarean 
delivery has also been highlighted in the latest confidential enquiries, with caesarean 
delivery having a 2,8-fold higher risk of mortality when compared to vaginal delivery. [26] 
When comparing the maternal morbidity and mortality associated with caesarean section 
with the fetal benefit and number needed to treat, one has to question the current practice 
of caesarean delivery in mothers with suspected macrosomic fetuses.  
 
As such, ultrasound fetal weight estimation as a predictor for fetal macrosomia should 
remain under scrutiny in the context of the high morbidity associated with caesarean 
section.  The focus needs to remain on improving both the accuracy of fetal weight 
estimation and the detection of macrosomic fetuses.   
 






The aim of this study is to assess the accuracy of ultrasound fetal weight estimation, 
performed in diabetic women with a singleton pregnancy at 36 weeks or more, at Groote 




•   To evaluate the institutional accuracy of ultrasound fetal weight estimation in 
singleton term pregnancies in women with gestational and pre-gestational diabetes, 
compared to birth weight. 
•   To determine the incidence of macrosomia in our study population. 




•   To compare the accuracy of ultrasound fetal weight estimation in diabetic patients 
at our institution to that of international study results. 
•   To review the practice of routine ultrasound fetal weight estimation at term in 
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CHAPTER 2  
 
Title:  Accuracy of estimated fetal weight using ultrasound at term in pregnant 
women diagnosed with gestational and pre-gestational diabetes at Groote 
Schuur Hospital 
 
Mareli Venter1, Leann Schoeman1 
 
1. Department of Obstetrics and Gynaecology Groote Schuur Hospital, University of 





The incidence of diabetes in pregnancy is rising globally. These patients are at risk of 
multiple perinatal complications, including macrosomia. In order to predict fetal 
macrosomia, fetal weight estimation remains an important component of antenatal 
surveillance.  
 
Objectives and methods 
This retrospective audit assessed the accuracy of ultrasound fetal weight estimation and 
the identification of macrosomia in diabetic women at term. Our study reviewed women 
with diabetes in pregnancy who attended antenatal services at Groote Schuur Hospital 
(GSH) during a 12-month period.   Patients at ≥ 36 weeks that underwent ultrasound fetal 
weight estimation within 7 days of delivery were included.  
 
Results 
Ninety-seven women in the study population met the inclusion criteria.  Ultrasound weight 
estimations were accurate to within 10% of birth weight in 70,1% of patients.  Eleven 
patients (11,3%) had macrosomic (> 4 000 g) babies.  In these patients, only 54,5% of 
fetal weight estimations were accurate to within 10% of birth weight.  Ultrasound for 
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The accuracy of ultrasound fetal weight estimation in diabetic patients at GSH appears 
similar to that of other international studies.  Ultrasound estimations become increasingly 
inaccurate in extremes of fetal weight.  One in four weight estimations had an estimation 
error of > 10% with a tendency towards underestimation in macrosomic fetuses. 
Ultrasound fetal weight estimation as a predictor for macrosomia should remain under 
scrutiny, especially in the context of the high perinatal morbidity associated macrosomia 




Diabetes mellitus has a rapidly rising global incidence with an alarming estimate of a 90% 
increase in incidence in Africa. The number of pregnancies complicated by diabetes is also 
on the rise. [1,2] 
 
In pregnancy, diabetes is associated with multiple perinatal complications. The diabetic 
mother is at an increased risk of pre-eclampsia and preterm labour. The fetus of the 
diabetic mother is at an increased risk of congenital malformations, perinatal mortality and 
stillbirth as well as fetal overgrowth (macrosomia) and its associated complications. [2]  
The exact definition of macrosomia remains contentious. The Royal College of 
Obstetricians and Gynaecologists (RCOG) defines macrosomia as a fetal weight at birth of 
5 000 g or more in normal pregnancies or a fetal weight at birth of 4 500 g or more in 
pregnancies affected by diabetes. [3] The American College of Obstetricians and 
Gynecologists (ACOG) is more conservative, with macrosomia defined as a fetal weight at 
birth greater than 4 500 g. Both fetal and maternal morbidity show a sharp increase at this 
cut off.  It is, however, recognized that there is a somewhat increased risk with a fetal 
weight at birth of more than 4 000 g, especially if the pregnancy is complicated by 
diabetes. [4] 
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Maternal risks specifically associated with a macrosomic fetus include prolonged or 
obstructed labour, assisted vaginal delivery, increased risk of caesarean delivery, perineal 
trauma, post-partum haemorrhage and uterine rupture.  The macrosomic fetus is at risk of 
shoulder dystocia, which can cause trauma to the fetus e.g. nerve injury or fractures. 
There is also an increased risk of birth asphyxia. [5] 
 
In order to predict fetal macrosomia, fetal weight estimation remains an important 
component of antenatal surveillance, especially in the late third trimester.  Prior to real-
time ultrasound being widely accessible, clinical fetal weight estimation was the gold 
standard but the accuracy was found to be relatively poor. [6] 
 
The initial assumption was that ultrasound fetal weight estimation would be superior to 
clinical estimates.  Ultrasound fetal weight estimation was compared to clinical 
examination to estimate fetal birth weight as well as maternal fetal weight estimation.   A 
number of studies have subsequently shown no significant difference between the 
accuracy of these different methods to estimate fetal weight. [7,8] However, at the extremes 
of fetal weight, clinical methods of fetal weight estimation become less accurate.  In low 
birth weight fetuses (< 2 500 g), ultrasound estimation of fetal weight has been shown to 
be more accurate than clinical estimation.  In the macrosomic (> 4 000 g) group both 
ultrasound and clinical estimates become more inaccurate. [9] 
 
Despite the relative inaccuracy of ultrasound fetal weight estimation, the current National 
Institute for Health and Care Excellence (NICE) guideline on the care of diabetic patients, 
recommends offering 4 weekly ultrasound scans from 28 to 36 weeks to assess fetal 
growth and wellbeing. [2] 
 
The South African national guidelines recommend a dating ultrasound for all patients.  In 
addition, it is recommended that diabetic patients have a screening ultrasound to exclude 
fetal abnormalities at 12 to 14 weeks, as well as a detailed fetal anatomy scan performed 
at 18 to 22 weeks at a specialist level hospital. [10] 
 
The current protocol for management of diabetic patients at Groote Schuur Hospital goes 
further and recommends growth scans at 4 weekly intervals starting at 28 weeks.  In 
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addition, the Western Cape guidelines recommend offering an elective caesarean section 
to diabetic patients with an estimated fetal weight of 4 000 g or more at term with a fetal 
abdominal circumference greater than the 90th percentile. [11] This is also the practice at 
the Maternity Centre at Groote Schuur Hospital and has subsequently resulted in a large 
number of caesarean deliveries performed to prevent fetal and maternal complications 
related to presumed macrosomia. 
 
There has been much debate on an acceptable caesarean section rate globally, with a 
wide range in both developed and developing countries.  The national caesarean section 
rate is 23% as published in the Saving Mothers report (2011– 2013).  Haemorrhage 
remains an important cause of maternal mortality both in South Africa and worldwide.  The 
high number of maternal deaths related to haemorrhage associated with caesarean 
delivery has also been highlighted in the latest confidential enquiries, with caesarean 
delivery having a 2,8-fold higher risk of mortality when compared to vaginal delivery. [12] 
 
As such, ultrasound fetal weight estimation as a predictor for fetal macrosomia should 
remain under scrutiny in the context of the multiple perinatal complications associated with 
macrosomia as well as the high morbidity associated with caesarean section.  The focus 
needs to remain on improving both the accuracy of fetal weight estimation and the 
detection of macrosomic fetuses.  It is also imperative to continuously audit the accuracy 
of ultrasound fetal weight estimation at our institution as well as assess the current 




This is a retrospective descriptive study for the 12-month period from 1 September 2010 to 
31 August 2011.  All women diagnosed with an abnormal glucose tolerance test (GTT) 
during pregnancy or known to have pre-existing diabetes attending the antenatal clinic 
services at Groote Schuur Hospital during the year in question, were included in the 
diabetic database.  Patients who had undergone a documented ultrasound fetal weight 
estimation at term (36 to 40 weeks) and delivered within 7 days from the ultrasound were 
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selected from this pre-existing approved database.  The exclusion criteria for this study 
were multiple pregnancies, intra-uterine fetal death and fetal abnormalities. 
  
Groote Schuur Hospital in Cape Town, South Africa is a Tertiary Level Hospital providing 
obstetric and neonatal services to a large drainage area consisting of multiple Midwife 
Obstetric Units (MOU’s), Level 1 as well as Level 2 Hospitals.  Patients with risk factors 
undergo screening GTT’s and patients with abnormal results (fasting glucose > 5,5 mmol/l 
or 2-hour glucose > 7,7 mmol/l) are then referred to either a Level 2 or a Level 3 care 
facility.  All patients who need medical intervention for diabetes diagnosed in pregnancy 
and all patients with pre-existing diabetes receive their antenatal care at a Level 3 Facility. 
 
It is routine practice at Groote Schuur Hospital to do an ultrasound fetal weight estimation 
in diabetic patients prior to delivery.  The investigation is done at 37 weeks’ gestation.  All 
ultrasounds were performed within the fetal medicine unit at Groote Schuur Hospital.  At 
this unit fetal weight estimations were done by various categories of staff that included 
ultrasonographers, medical officers, fetal maternal specialists and registrars. 
 
This study was undertaken to evaluate the institutional accuracy of ultrasound fetal weight 
estimation when compared to actual birth weight in singleton term pregnancies in women 
with gestational and pre-gestational diabetes, as well as to determine the incidence of 
macrosomia in our study population and the rate of accurate identification of macrosomia 
in these patients.  Secondary objectives were to compare the accuracy of ultrasound fetal 
weight estimation at our institution to that of international study results and to review the 
practice of routine ultrasound fetal weight estimation at term in diabetic patients to guide 




Of the 725 patients entered into the diabetic database, 596 had live born singleton 
pregnancies at 36 weeks or later gestation.  Of those patients, 97 had a documented 
ultrasound fetal weight estimation done within 7 days of delivery. 
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In the index study, the average age was 31,2 years with a range of 19 to 45 years.  The 
average parity was 1,6 with a range of 0 to 5.  Twenty-five of the 97 patients (25,7%) 
included were nulliparous. The average weight was 87,7 kg with a range of 49 to 153 kg. 
Seventy-three (75,3%) had height captured and BMI calculated.  The average BMI was 
34,7 with a range of 18,7 to 52,4.  Only 10 women (13,7%) had a normal BMI (18,5 – 
25,0).  Nineteen women (26%) are classified as morbidly obese with a BMI of > 40.  
Seventy women (72,2%) in the study cohort had gestational diabetes of which 48 had 
impaired glucose tolerance and 22 had gestational diabetes.  Twenty-seven (27,8%) had 
pre-gestational diabetes with 25 patients (25,7%) diagnosed with type 2 diabetes and 2 
patients (2,1%) with type 1 diabetes.  
The mean actual birth weight in the study cohort was 3 394 g (range 2 255 – 5 240 g). 
Eleven patients (11,3%) gave birth to macrosomic babies (birth weight >4 000 g). Four of 
these babies weighed more than 4 500 g and 1 more than 5 000 g. (Table 1) 
 
 Mean Actual BW < 2 500 g 2 500 – 
3 999 g 
4 000 – 
4 500 g 
> 4 500 g Total: 
IGT 3 332 g 
(range 2 255 – 5 240 g) 
3 41 3 1 48 
GDM 3 587 g 
(range 2 550 – 4 860 g) 
0 19 1 2 22 
DM2 3 295 g 
(range 2 500 – 4 575 g) 
0 22 2 1 25 
DM1 4 022 g 
(range 3 940 – 4 105 g) 
0 1 1 0 2 
Total 3 394 g 












Table 1 – Birth weight distribution 
BW = Birth Weight, IGT = Impaired glucose tolerance, GDM = Gestational diabetes, DM2 = Type 2 diabetes, 
DM1 = Type 1 diabetes 
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The average time interval between the ultrasound fetal weight estimation and delivery in 
the study cohort was 4,5 days. The average time interval between ultrasound and delivery 
for patients with IGT was 4,3 days, 4,0 days for patients with GDM, 4,9 days for patients 
with type 2 DM and 6,5 days for patients with type 1 DM. 
 
When comparing estimated fetal weight to birth weight, ultrasound estimation was 
accurate to within 10% of birth weight in 68 out of 97 patients (70,1%).  In macrosomic 
babies the distribution of error appears to be an underestimation of weight rather than an 
overestimation.  There were no estimations in this weight category found to be more than 
10% of actual birth weight. (Table 2) 
 
 < 3 000 g 
n = 16 (16,5%) 
3 000 – 3 999 
g 
n = 70 (72,2%) 
4 000 – 4 499 g  
n = 7 (7,2%) 
> 4 500 g 
n = 4 (4,1%) 
Total 
n = 97 
Within 10% of 
BW 
13 (81,2%) 49 (70%) 3 (42,9%) 3 (75%) 68 (70,1%) 
>10% below BW 1  (6,3%) 13 (18,6%) 4 (57,1%) 1 (25%) 19 (19,6%) 
>10% above 2 (12,5%) 8 (11,4%) 0 (0%) 0 (0%) 10 (10,3%) 




The accuracy of ultrasound estimation between the different diabetic groups varied from 
54,5% to 100% (Table 3). However, the error distribution showed a tendency towards 
underestimation rather than overestimation of weight in the impaired glucose tolerance 
(IGT) and the gestational diabetes (GDM) subgroups.  The accuracy of estimated fetal 
weight (EFW) to within 10% of birth weight among type 1 diabetics was 100% although 
numbers in this group were small (n=2).   
 
 
Table 2 – Birth weight distribution 
BW = Birth Weight 















n = 97 
Within 10% of BW 37 (77,1%) 12 (54,5%) 17 (68,0%) 2 (100%) 68 
>10% below BW 7 (14,6%) 8 (36,4%) 4 (16,0%) 0 (0%) 19 
> 10% above BW 4 (8,3%) 2 (9,1%) 4 (16,0%) 0 (0%) 10 




Of the 11 patients with macrosomia, 7 (63,6%) were correctly estimated by ultrasound to 
be more than 4 000 g. Therefore, 4 out of 11 patients (36,4%) with macrosomic infants 
were not accurately diagnosed.  Ultrasound estimation incorrectly identified macrosomia in 
3 patients (3,5%). When ultrasound prediction of birth weight is greater than 4 000 g, 
ultrasound had a sensitivity of 58,3% (CI: 36 - 82%), specificity of 96,5% (CI: 93 - 99%), 
positive predictive value of 70% (CI: 39 - 90%) and negative predictive value of 94,3% (CI: 
92 - 98%). 
 
In the 4 patients where macrosomia was not correctly identified by ultrasound estimation, 
the birth weight was underestimated by more than 10%, and two of these patients were 
delivered via emergency caesarean section for cephalo-pelvic disproportion (Table 4). In 
the 3 patients where ultrasound estimation incorrectly identified macrosomia, 2 patients 
had caesarean sections. These 3 patients had a maternal weight of more than 90 kg in 





Table 3 - Error distribution per diabetic group 
IGT = Impaired glucose tolerance, GDM = Gestational diabetes, DM2 = Type 2 diabetes, DM1 = Type 1 diabetes, 
BW = Birth weight 




 Age Maternal 
weight 










US done by MOD and 
indication 
1 31 82 3 DM2 3 439 4 030 14,7 1 Registrar CS - 
Macrosomia 
2 27 153 0 DM2 3 530 4 120 14,3 5 Sonographe
r 
CS - CPD 




4 36 140 3 IGT 3 642 4 050 10,1 5 Sonographe
r 
















US done by MOD and 
indication 
1 41 94 5 DM2 4 287 3 850 11,4 4 Sonographer CS - 
Macrosomia 
2 40 99 4 GDM 4 024 3 580 12,4 0 Sonographer NVD 





Table 4 - Macrosomia not correctly identified 
P = Parity, DM = Diabetes Mellitus, EFW = Estimated fetal weight, BW = Birth weight, US = Ultrasound, MOD = Mode of 
delivery, DM2 = Type 2 diabetes, GDM = Gestational diabetes, IGT = Impaired glucose tolerance, CS = Caesarean section, 
CPD = Cephalo-pelvic disproportion 
Table 5 - Macrosomia incorrectly diagnosed 
P = Parity, DM = Diabetes Mellitus, EFW = Estimated fetal weight, BW = Birth weight, US = Ultrasound, MOD = Mode of 
delivery, DM2 = Type 2 diabetes, GDM = Gestational diabetes, CS = Caesarean section, NVD = Normal vertex delivery 
 















Previous CS Abnormal Lie Macrosomia Fetal Distress CPD Placenta praeviaFailed IOL
Indications for CS
Delivery details were available for the entire cohort.  Caesarean section was performed in 
52 patients (53,6%).  In 12 of the 52 patients, the indication for caesarean was 
macrosomia.  The remaining 30 patients were delivered for other obstetric indications 












Figure 1 - Indications for CS 




Incidence of macrosomia in diabetic population 
A review done by Chauhan et al. in the US in 2004 on the incidence of macrosomia 
(defined as > 4 000 g) in the general population, found a wide range worldwide.  The 
incidence ranged from 1 – 28%.  This wide range could be explained by a difference in the 
incidence of obesity and diabetes in different countries, as well as different ethnicity. No 
clear trend between low middle-income countries and high-income countries was found. 
[13] 
 
  Page |31 
 
 
A study done by Wong et al. in Australia in 2001 found a 19% incidence of macrosomia in 
diabetic mothers included in the study.  This study included both pre-gestational and 
gestational diabetics.  There is limited data with respect to the incidence of macrosomia in 
the diabetic pregnant population in South Africa. [14] 
 
The incidence of macrosomia in this study cohort was 11,3%.  This compares well to the 
overall incidence of macrosomia in diabetic patients at Groote Schuur Hospital for this 
period (10,5%).  As the incidence of diabetes in pregnancy increases, the rate of 
macrosomia is also expected to rise.  This poses potential difficulty in maintaining a 
standard of care in a resource-limited setting, where ultrasound fetal weight estimations 
require operator expertise as well as advanced equipment. 
 
Accuracy of EFW with US 
In our retrospective review of 97 patients with diabetes in pregnancy, ultrasound fetal 
weight estimation at term done within 7 days of delivery correlated well with actual birth 
weight.  Seventy percent of ultrasound estimations had an accuracy to within 10% of birth 
weight.  This is comparable to that of similar international studies.  
 
Colman et al. found similar results in a study done in New Zealand in 2006 assessing 
ultrasound weight estimation accuracy.  This study found that 74,8% of fetal weight 
estimations were within 10% of birth weight in the general population.  This study included 
1 177 women, of which only 48 women were diabetic.  Upon analysis of women with 
diabetes, 71% of weight estimations where within 10% of birth weight.  Similarly, the 
overall accuracy to within 10% of birth weight in the index study was 70,1%.  [15] 
 
Colman demonstrated that the underestimation of fetal weight was significantly more 
common in diabetic patients than non-diabetic patients.  In his study the trend to 
underestimation in diabetic patients was similar in both the normal weight group (27%) and 
macrosomic group (31%). [15] This is similar to the findings in our study, which also shows 
a marked tendency towards underestimation in the macrosomic group. However, when 
analyzing only women with macrosomic infants, 54,5% were accurately estimated to within 
10% of birth weight.  There was a clear trend towards underestimation of fetal weight 
(45,5%).  None of the macrosomic infants’ weights were overestimated by more than 10%. 




Accuracy of macrosomia identification 
The reliability of prediction of fetal weight greater than 4 000 g is of specific importance in 
diabetic pregnancies at higher risk of macrosomia and its associated morbidity.  Colman et 
al. found ultrasound to have a sensitivity of 61% (CI: 53–68%) and specificity of 96% (CI: 
94 - 97%) in non-diabetic patients. [15] Our study cohort compared favourably with a 
sensitivity of 58,3% (CI: 36 - 82%) and specificity of 96,5% (CI: 93 - 99%). In our cohort 
ultrasound correctly diagnosed 2 out of every 3 cases of macrosomia. 
 
On reviewing the above results, it would be reasonable to continue the current practice of 
doing an ultrasound fetal weight estimation in the diabetic patients within 7 days of delivery 
to screen for macrosomia and make recommendations regarding mode of delivery.   
 
The strength of this study is that we now have data about the accuracy of ultrasound fetal 
weight estimation in our local population and our ultrasound service.  Limitations of this 
study include the small sample size as well as it having been done retrospectively.  A 




The accuracy of ultrasound EFW performed in diabetic patients at GSH appears similar to 
that of other international studies.  Ultrasound estimations become increasingly inaccurate 
in extremes of fetal weight and increased maternal BMI.  One in four women undergoing 
ultrasound fetal weight estimation had an estimation error of >10% with a tendency 
towards underestimation of weight in macrosomic fetuses. Ultrasound fetal weight 
estimation as a predictor for fetal macrosomia should therefore remain under scrutiny, 
especially in the context of the high perinatal morbidity associated macrosomia and 
shoulder dystocia as well as the rising litigation associated with birth complications.  The 
focus needs to remain on improving both the accuracy of fetal weight estimation and the 
detection of macrosomic fetuses.  It is also imperative to continuously audit the accuracy 
of ultrasound fetal weight estimation at our institution as well as assess the current 
practice in the light of restricted resources.   
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